SCHEMBL2235538

SCHEMBL2235538

CCCCC1=CC(C)([Zr]C2(C)C=CC(CCCC)=C2)C=C1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SKP2 Q13309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16223757 0.96 LIPG (0.31)
SCHEMBL2234751 0.88
SCHEMBL2236111 0.79
Bromide SCHEMBL21410479 0.76 SKP2 (0.30) SKP2
Hydrochloric Acid SCHEMBL182956 0.76 SKP2 (0.30) SKP2
SCHEMBL9234542 0.76
Fluoride Ion SCHEMBL2233516 0.76 SKP2 (0.30) SKP2
Hydrochloric Acid SCHEMBL7627626 0.74 SKP2 (0.32) SKP2
SCHEMBL7544525 0.74 SKP2 (0.32) SKP2
SCHEMBL7630215 0.73 NPC1 (0.33) SKP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260098112-A1 METHOD OF MAKING A MORPHOLOGY-IMPROVED POLYETHYLENE POWDER DOW GLOBAL TECHNOLOGIES LLC (US) 2026-04-09 US claimed
US-12528892-B2 Alkylation of transition metal coordination catalyst complexes EXXONMOBIL CHEMICAL PATENTS INC. (US) 2026-01-20 US claimed
EP-4638526-A1 METHOD OF MAKING A MORPHOLOGY-IMPROVED POLYETHYLENE POWDER Dow Global Technologies LLC (US) 2025-10-29 EP claimed
EP-3697822-B1 MIXED CATALYSTS WITH UNBRIDGED HAFNOCENES WITH -CH2-SIME3 MOIETIES EXXONMOBIL CHEMICAL PATENTS INC (US) 2025-07-30 EP claimed
EP-3728350-B1 ZIRCONOCENE-TITANOCENE CATALYST SYSTEM DOW GLOBAL TECHNOLOGIES LLC (US) 2024-03-13 EP claimed
US-20230357454-A1 Methods for Delivery of Non-Aromatic Solutions to Polymerization Reactors EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-11-09 US claimed
EP-4192888-A1 METHODS FOR DELIVERY OF NON-AROMATIC SOLUTIONS TO POLYMERIZATION REACTORS ExxonMobil Chemical Patents Inc. (US) 2023-06-14 EP claimed
US-20230141606-A1 Alkylation of Transition Metal Coordination Catalyst Complexes EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-05-11 US claimed
EP-3980491-B1 POLYETHYLENE BLEND UNIVATION TECH LLC (US) 2023-05-03 EP claimed
EP-3583140-B1 SUPPORTED CATALYST SYSTEMS AND PROCESSES FOR USE THEREOF EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-03-08 EP claimed
US-11485802-B2 Spray-dried zirconocene catalyst system DOW GLOBAL TECHNOLOGIES LLC (US) 2022-11-01 US claimed
US-11421051-B2 Zirconocene-titanocene catalyst system DOW GLOBAL TECHNOLOGIES LLC (US) 2022-08-23 US claimed
US-20220213302-A1 POLYETHYLENE BLEND UNIVATION TECH LLC (US) 2022-07-07 US claimed
EP-3980491-A1 POLYETHYLENE BLEND Univation Technologies, LLC (US) 2022-04-13 EP claimed
EP-2776476-B1 METHODS FOR PRODUCING POLYOLEFINS WITH CATALYST SYSTEMS UNIVATION TECH LLC (US) 2019-03-13 EP claimed
EP-1910432-B1 PROCESS TO PRODUCE LOW VISCOSITY POLY-ALPHA-OLEFINS EXXONMOBIL CHEM PATENTS INC (US) 2014-11-12 EP claimed
EP-1799726-B1 TRIALKYLALUMINUM TREATED SUPPORTS EXXONMOBIL CHEM PATENTS INC (US) 2011-07-13 EP claimed
EP-1608690-B1 PREPARATION OF POLYOLEFINS HAVING HIGH MOLECULAR WEIGHTS IN THE PRESENCE OF AN ORGANIC TRANSITION METAL COMPOUND IN A GAS-PHASE FLUIDIZED-BED REACTOR BASELL POLYOLEFINE GMBH (DE) 2007-06-13 EP claimed
EP-0843687-B1 METALLOCENE STABILIZED ALUMOXANE EXXONMOBIL CHEM PATENTS INC (US) 2002-06-12 EP claimed
EP-0879250-B1 IMPROVED SUPPORTED METALLOCENE CATALYST SYSTEMS EXXON CHEMICAL PATENTS INC (US) 2000-09-20 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528892-B2 Alkylation of transition metal coordination catalyst complexes LEF1, TAF1, FLI1 SKP2 3484/4885
US-20230141606-A1 Alkylation of Transition Metal Coordination Catalyst Complexes AS3MT, AP1M1, AP3M1 SKP2 2137/4885
US-20260098112-A1 METHOD OF MAKING A MORPHOLOGY-IMPROVED POLYETHYLENE POWDER AMY1A, ELP1, POF1B SKP2 1144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.